138 related articles for article (PubMed ID: 8428713)
1. Effect of fatty acid oxidation inhibition on glucose metabolism in diabetic rats.
Collier GR; Traianedes K; Macaulay SL; O'Dea K
Horm Metab Res; 1993 Jan; 25(1):9-12. PubMed ID: 8428713
[TBL] [Abstract][Full Text] [Related]
2. The longitudinal effect of inhibiting fatty acid oxidation in diabetic rats fed a high fat diet.
Barnett M; Collier GR; O'Dea K
Horm Metab Res; 1992 Aug; 24(8):360-2. PubMed ID: 1526621
[TBL] [Abstract][Full Text] [Related]
3. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
4. Reduced effects of L-carnitine on glucose and fatty acid metabolism in myocytes isolated from diabetic rats.
Abdel-aleem S; Karim AM; Zarouk WA; Taylor DA; el-Awady MK; Lowe JE
Horm Metab Res; 1997 Sep; 29(9):430-5. PubMed ID: 9370110
[TBL] [Abstract][Full Text] [Related]
5. Co-administration of etomoxir and RU-486 mitigates insulin resistance in hepatic and muscular tissues of STZ-induced diabetic rats.
Bitar MS
Horm Metab Res; 2001 Oct; 33(10):577-84. PubMed ID: 11607876
[TBL] [Abstract][Full Text] [Related]
6. The effect of inhibiting fatty acid oxidation on basal glucose metabolism in Psammomys obesus.
Barnett M; Habito R; Cameron-Smith D; Yamamoto A; Collier GR
Horm Metab Res; 1996 Apr; 28(4):165-70. PubMed ID: 8740190
[TBL] [Abstract][Full Text] [Related]
7. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
[TBL] [Abstract][Full Text] [Related]
8. [Change of glucose transporter 4 and its influence on glucose and fatty-acid metabolism in type 2 diabetic myocardium].
Wen ZY; Wu Y; Li Y; Chen XL; Wang T; Ouyang JP; Li GS
Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1460-3. PubMed ID: 16061022
[TBL] [Abstract][Full Text] [Related]
9. Reduced induction of carbohydrate utilization by inhibition of fatty acid oxidation in myocytes from diabetic animals.
Abdel-aleem S; Sharwi S; Badr M; Sayed-Ahmed M; Anstadt MP; Lowe JE
Horm Metab Res; 1995 Feb; 27(2):104-6. PubMed ID: 7759056
[No Abstract] [Full Text] [Related]
10. Reduction in hyperglycemia by mild food restriction in streptozotocin induced diabetic rats improves insulin sensitivity.
Cameron-Smith D; Collier GR; O'Dea K
Horm Metab Res; 1994 Jul; 26(7):316-21. PubMed ID: 7959606
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of aloe vera leaf gel extract on lipid profile status in rats with streptozotocin diabetes.
Rajasekaran S; Ravi K; Sivagnanam K; Subramanian S
Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):232-7. PubMed ID: 16487267
[TBL] [Abstract][Full Text] [Related]
12. Effect of the fatty acid oxidation inhibitor methyl palmoxirate (methyl 2-tetradecylglycidate) on recovery from insulin-induced hypoglycemia in diabetic dogs.
Tuman RW; Bowden CR; Inman M; Altszuler N; Tutwiler GF
J Pharmacol Exp Ther; 1989 Sep; 250(3):836-41. PubMed ID: 2674419
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of ursolic acid on hepatic polyol pathway and glucose production in streptozotocin-induced diabetic mice.
Jang SM; Kim MJ; Choi MS; Kwon EY; Lee MK
Metabolism; 2010 Apr; 59(4):512-9. PubMed ID: 19846180
[TBL] [Abstract][Full Text] [Related]
14. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels.
Stefanovic-Racic M; Perdomo G; Mantell BS; Sipula IJ; Brown NF; O'Doherty RM
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E969-77. PubMed ID: 18349115
[TBL] [Abstract][Full Text] [Related]
15. Effects of the carnitine-acyltransferase inhibitor etomoxir on insulin sensitivity, energy expenditure and substrate oxidation in NIDDM.
Hübinger A; Knode O; Susanto F; Reinauer H; Gries FA
Horm Metab Res; 1997 Sep; 29(9):436-9. PubMed ID: 9370111
[TBL] [Abstract][Full Text] [Related]
16. Regulation of glucose utilization during the inhibition of fatty acid oxidation in rat myocytes.
Abdel-aleem S; Li X; Anstadt MP; Perez-Tamayo RA; Lowe JE
Horm Metab Res; 1994 Feb; 26(2):88-91. PubMed ID: 8200620
[TBL] [Abstract][Full Text] [Related]
17. Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Zinker B; Mika A; Nguyen P; Wilcox D; Ohman L; von Geldern TW; Opgenorth T; Jacobson P
Metabolism; 2007 Mar; 56(3):380-7. PubMed ID: 17292727
[TBL] [Abstract][Full Text] [Related]
18. Improvement of myocardial function and metabolism in diabetic rats by the carnitine palmitoyl transferase inhibitor Etomoxir.
Schmitz FJ; Rösen P; Reinauer H
Horm Metab Res; 1995 Dec; 27(12):515-22. PubMed ID: 8750778
[TBL] [Abstract][Full Text] [Related]
19. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
20. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
Rösen P; Reinauer H
Acta Physiol Hung; 1988; 71(2):271-80. PubMed ID: 3389170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
